Prevention of infection complications of the knee joint replacement
I.F. AKHTYAMOV1,2, D.V. RIMASHEVSKIY3, E.D. KURMANGALIYEV3, Zh.M. MOLDAKULOV4, I.K. EREMIN2
1Republican Clinical Hospital of the Ministry of Health of the Republic of Tatarstan, 138 Orenburgskiy Trakt, Kazan, Russian Federation, 420064
2Kazan State Medical University, 49 Butlerova St., Kazan, Russian Federation, 420012
3Karaganda RegionalCenterof Traumatology and Orthopedics named after Prof. Kh.Zh.Makazhanov, 13 Sacken Seyfullin Prospekt, Karaganda, Kazakhstan, 100019
4Municipal Clinical Hospital № 4, 220 Papanina Str, Almaty, Kazakhstan
AkhtyamovI.F. — D. Med. Sc., Professor, Head ofthe Department of Traumatology, Orthopedicsand Surgeryof Extreme States of KSMU, Chief Researcherof the Scientific DepartmentRCH of MH of RT, tel. +7-905-315-01-50, e-mail: yalta60@mail.ru1,2
RimashevskyD.V. — consultant of Karaganda RegionalCentre of Traumatologyand Orthopedics named after Prof. Kh.Zh.Makazhanov, +7 (7212) 41-85-35, e-mail: drimashe@gmail.com3
KurmangaliyevE.-D.T.— Deputy ChiefDoctor of KaragandaRegionalCenter of Traumatologyand Orthopedicsnamed after Prof. Kh.Zh.Makazhanov, tel. +7 (7212) 41-85-35, e-mail: makazhanov@gmail.com3
Moldakulov Z.M. —Deputy Chief Doctor, tel. +7-727-300-36-04, e-mail: info@gkb4.kz4
Eremin I.K.— applicant of the Departmentof Traumatology, Orthopadicsand Surgeryof Extreme States, tel. (843) 269-50-15, e-mail: eremindoktor@jandex.ru2
Infection complications after knee joint replacement is a serious medical and social problem. The frequency of infection complications achieves 7% in western countries. Infection prevention requires maximum effort both during the patient’s preparation for operation, and during and after implanting the prosthesis. The results of several researches on the efficiency of knee replacement septic complications prophylaxis have been published recently. The article presents the review of some of these publications.
Key words: knee joint, paraprosthetic infection, revision joint replacement.
REFERENCES
1. Vessely M.B., Whaley A.L., Harmsen W.S. et al. Long-term survivorship and failure modes of 1000 cemented condylar total knee arthroplasties, Clin. Orthop. Relat. Res., 2006, no. 452, pp. 28-34.
2. Fehring T.K., Odum S., Griffin W.L., Mason J.B. et al. Early failures in total knee arthroplasty, Clin. Orthop. Relat. Res., 2001, Nov., no. 392, pp. 315-8.
3. Bozic K.J., Kurtz S.M., Lau E., Ong K. et al. The epidemiology of revision total knee arthroplasty in the United States, Clin. Orthop. Relat. Res., 2010, no. 468, pp. 45-51.
4. Kurtz S.M., Ong K.L., Lau E., Bozic K.J. et al. Prosthetic joint infection risk after TKA in the Medicare population, Clin. Orthop. Relat. Res., 2010, no. 468, pp. 52-6.
5. Rao N., Cannella B., Crossett L.S., Yates A.J. Jr. et al. A preoperative decolonization pro- tocol for Staphylococcus aureus prevents orthopaedic infections, Clin. Orthop. Relat. Res., 2008, no. 466, pp. 1343-8.
6. Price C.S., Williams A., Philips G., Dayton M. et al. Staphylococcus aureus nasal colonization in preoperative orthopaedic outpatients, Clin. Orthop. Relat. Res., 2008, no. 466, pp. 2842-7.
7. Kuehnert M.J., Kruszon-Moran D., Hill H.A., McQuillan G. et al. Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002, J. Infect. Dis., 2006, Jan 15, no. 193 (2), pp. 172-9, Epub., 2005, Dec 15.
8. Gorwitz R.J., Kruszon-Moran D., McAllister S.K., McQuillan G. et al. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004, J. Infect. Dis., 2008, May 1, no. 197 (9), pp. 1226-34.
9. Ya K., Mida Y., Sakawa A., Kuwa Y. et al. Positive nasal culture of methicillin-resistant Staphylococcus aureus (MRSA) is a risk factor for surgical site infection in orthopedics, Acta Orthop., 2009, Aug., no. 80 (4), pp. 486-90.
10. Kalmeijer M.D., Van Nieuwland-Bollen E., Bogaers-Hofman D., de Baere G.A. Nasal carriage of Staphylococcus aureus is a major risk factor for surgical-site infections in orthopedic surgery, Infect. Control. Hosp. Epidemiol., 2000, May, no. 21 (5), pp. 319-23.
11. Berthelot P., Grattard F., Cazorla C., Passot J.P. et al. Is nasal carriage of Staphylococcus aureus the main acquisition pathway for surgical-site infection in orthopaedic surgery? Eur. J. Clin. Microbiol. Infect. Dis., 2010, Apr., 29 (4), pp. 373-82, Epub. 2010, Jan 28.
12. Illingworth K.D., Mihalko W.M., Parvizi J., Sculco T. et al. How to Minimize Infection and Thereby Maximize Patient Outcomes in Total Joint Arthroplasty: A Multicenter Approach AAOS Exhibit Selection, J. Bone. Joint. Surg. Am., 2013, no. 95, e 50, pp. 1-13.
13. Garvin K.L., Konigsberg B.S. Infection Following Total Knee Arthroplasty Prevention and Management, J. Bone. Joint. Surg. Am., 2011, no. 93, pp. 1167-75.
14. Hidron A.I., Kourbatova E.V., Halvosa J.S., Terrell B.J. et al. Risk factors for colonization with methicillin-resistant Staphylococcus aureus (MRSA) in patients admitted to an urban hospital: emergence of community-associated MRSA nasal carriage, Clin. Infect. Dis., 2005, Jul 15, no. 41 (2), pp. 159-66. Epub. 2005, Jun 8.
15. Graham P.L. 3rd, Lin S.X., Larson E.L. A U.S. population-based survey of Staphylococcus aureus colonization, Ann. Intern. Med., 2006, Mar 7, no. 144 (5), pp. 318-25.
16. Rao N., Cannella B.A., Crossett L.S., Yates A.J. et al. Preoperative screening/decolonization for Staphylococcus aureus to prevent orthopedic surgical site infection: prospective cohort study with 2-year follow-up, J. Arthroplasty., 2011, Dec., no. 26(8)., pp. 1501-7. Epub. 2011, Apr 19.
17. Kim D.H., Spencer M., Davidson S.M., Li L. et al. Institutional prescreening for detection and eradication of methicillin-resistant Staphylococcus aureus in patients undergoing elective orthopaedic surgery, J. Bone Joint. Surg. Am., 2010, Aug 4, no. 92 (9), pp. 1820-6. Epub. 2010, Jul 7.
18. Buehlmann M, Frei R, Fenner L., Dangel M. et al. Highly effective regimen for decolonization of methicillin-resistant Staphylococcus aureus carriers, Infect. Control Hosp. Epidemiol., 2008, Jun., no. 29 (6), pp. 510-6.
19. Wendt C., Schinke S., Württemberger M., Oberdorfer K. et al. Value of whole-body washing with chlorhexidine for the eradication of methicillin-resistant Staphylococcus aureus: a randomized, placebo-controlled, double-blind clinical trial. Infect. Control Hosp. Epidemiol., 2007, Sep., no. 28 (9), pp. 1036-43. Epub. 2007, Jul 3.
20. Zywiel M.G., Daley J.A., Delais R.E., Naziri Q. et al. Advance preoperative chlorhexidine reduces the incidence of surgical site infections in knee arthroplasty. Int. Orthop., 2011, Jul., no. 35 (7), pp. 1001-6. Epub. 2010, Jun 20.
21. Courville X.F., Tomek I.M., Kirkland K.B., Birhle M. et al. Cost-effectiveness of preoperative nasal mupirocin treatment in preventing surgical site infection in patients undergoing total hip and knee arthroplasty: a cost-effectiveness analysis. Infect. Control Hosp. Epidemiol., 2012, Feb., no. 33 (2), pp. 52-9.
22. Malinzak R.A., Ritter M.A., Berend M.E., Meding J.B. et al. Morbidly obese, diabetic, younger, and unilateral joint arthroplasty patients have elevated total joint arthroplasty infection rates, J. Arthroplasty., 2009, Sep., no. 24, 6 Suppl., pp. 84-8. Epub. 2009, Jul. 15.
23. Namba R.S., Paxton L., Fithian D.C., Stone M.L. Obesity and perioperative morbidity in total hip and total knee arthroplasty patients, J. Arthroplasty., 2005, Oct., no. 20 (7 Suppl 3), pp. 46-50.
24. Dowsey M.M., Choong P.F. Obese diabetic patients are at substantial risk for deep infection after primary TKA, Clin. Orthop. Relat. Res., 2009, Jun., no. 467 (6), pp. 1577-81. Epub. 2008, Oct. 8.
25. Tannenbaum D.A., Matthews L.S., Grady-Benson J.C. Infection around joint replacements in patients who have a renal or liver transplantation, J. Bone. Joint. Surg. Am., 1997, Jan., no. 79 (1), pp. 36-9.
26. Sharma S., Nicol F., Hullin M.G, McCreath S.W. Long-term results of the uncemented low contact stress total knee replacement in patients with rheumatoid arthritis, J. Bone Joint. Surg. Br., 2005, Aug., no. 87 (8), pp. 1077-80.
27. Powell D.L., Whitener C.J., Dye C.E., Ballard J.O. et al. Knee and hip arthroplasty infection rates in persons with haemophilia: a 27 year single center experience during the HIV epidemic, Haemophilia., 2005, May, no. 11 (3), pp. 233-9.
28. Silva M., Luck J.V. Jr. Long-term results of primary total knee replacement in patients with hemophilia, J. Bone Joint., Surg. Am., 2005, Jan., no. 87 (1)., P. 85-91.
29. Iorio R., Williams K.M., Marcantonio A.J., Specht L.M. Diabetes mellitus, hemoglobin A1C, and the incidence of total joint arthroplasty infection, J. Arthroplasty., 2012, May, no. 27 (5), pp. 726-9.e1. Epub., 2011, no. 4.
30. Mraovic B., Suh D., Jacovides C., Parvizi J. Perioperative hyperglycemia and postoperative infection after lower limb arthroplasty, J. Diabetes. Sci. Tech., 2011, Mar 1, no. 5 (2), pp. 412-8.
31. Marchant M.H. Jr., Viens N.A., Cook C., Vail T.P. et al. The impact of glycemic control and diabetes mellitus on perioperative outcomes after total joint arthroplasty, J. Bone. Joint. Surg. Am., 2009, Jul., no. 91 (7), pp. 1621-9.
32. Pulido L., Ghanem E., Joshi A., Purtill J.J. et al. Periprostheticjointinfection: the incidence, timing, and predisposing factors, Clin. Orthop. Relat. Res., 2008, Jul., no. 466 (7), pp. 1710-5. Epub. 2008, Apr 18.
33. Bozic K.J., Lau E., Kurtz S., Ong K., Berry D.J. Patient-related risk factors for post- operative mortality and periprosthetic joint infection in medicare patients undergoing TKA, Clin. Orthop. Relat. Res., 2012, Jan., no. 470 (1), pp. 130-7.
34. Malinzak R.A., Ritter M.A., Berend M.E., Meding J.B. Morbidly obese, diabetic, younger, and unilateral joint arthroplasty patients have elevated total joint arthroplasty infection rates, J. Arthroplasty., 2009, Sep., no. 24, 6 Suppl., pp. 84-8. Epub 2009, Jul. 15.
35. Winiarsky R., Barth P., Lotke P. Total knee arthroplasty in morbidly obese patients, J. Bone. Joint. Surg. Am., 1998, Dec., no. 80 (12), pp. 1770-4.
36. Prokuski L. Prophylactic antibiotics in orthopaedic surgery, J. Am. Acad. Orthop. Surg., 2008, May., no. 16 (5)., P. 283-93.
37. Gilliam D.L., Nelson C.L. Comparison of a one-step iodophor skin preparation versus traditional preparation in total joint surgery, Clin. Orthop. Relat. Res., 1990, Jan., no. 250, pp. 258-60.
38. Mishriki S.F., Law D.J., Jeffery P.J. Factors affecting the incidence of postoperative wound infection, J. Hosp. Infect., 1990, Oct., no. 16 (3), pp. 223-30.
39. Kurtz S., Ong K., Lau E., Mowat F., Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030, J. Bone Joint. Surg. Am., 2007, Apr., no. 89 (4), pp. 780-5.
40. Johnston D.H., Fairclough J.A., Brown E.M., Morris R. Rate of bacterial recolonization of the skin after preparation: four methods compared, Br. J. Surg., 1987, Jan., no. 74 (1), p. 64.
41. Illingworth K.D., Mihalko W.M., Parvizi J., Sculco T. et al. How to Minimize Infection and Thereby Maximize Patient Outcomes in Total Joint Arthroplasty: A Multicenter Approach., J. Bone Joint . Surg. Am., 2013, no. 95, e50, pp. 1-13.
42. Ritter M.A. Operating room environment, Clin. Orthop. Relat. Res., 1999, no. Dec., 369, pp. 103-9.
43. Brown N.M., Cipria C.A., Moric M., Sporer S.M. et al. Dilute Betadine lavage before closure for the prevention of acute postoperative deep periprosthetic joint infection, J. Arthroplasty., 2012, Jan., no. 27 (1), pp. 27-30. Epub. 2011, May 8.
44. Cheng M.T., Chang M.C., Wang S.T., Yu W.K. et al. Efficacy of dilute Betadine solution irrigation in the prevention of postoperative infection of spinal surgery, Spine (Phila Pa 1976), 2005, Aug. 1., no. 30 (15), pp. 1689-93.
45. Barry A.L., Craig W.A., Nadler H., Barth Reller L. Methods for determining bactericidal activity of antimicrobial agents; approved guideline, 1999, available at: http://isoforlab.com/phocadownload/csli/M26-A.pdf
46. Becerro de Bengoa Vallejo R., Losa Iglesias ME, Cervera L.A., Fernandez D.S., Prieto JP. Efficacy of intraoperative surgical irrigation with polihexanide and nitrofurazone in reducing bacterial load after nail removal surgery, J. Am. Acad. Dermatol., 2011, Feb., no. 64 (2), pp. 328-35. Epub 2010, no. 26.
47. Seiberling K.A., McHugh R.K., Aruni W., Church C.A. The impact of intraoperative saline irrigations on bacterial load within the maxillary sinus, Int. Forum Allergy Rhi., no. l, 2011, Sep-Oct; no.1 (5), pp. 351-5. Epub 2011, Jun. 14.
48. Hirsch T., Koerber A., Jacobsen F., Dissemond J. et al. Evaluation of toxic side effects of clinically used skin antiseptics in vitro, J. Surg. Res., 2010, Dec., no. 164(2), pp. 344-50. Epub. 2009, May.
49. Muller G., Kramer A. Comparative study of in vitro cytotoxicity of povidone-iodine in solution, in ointment or in a liposomal formulation (Repithel) and selected antiseptics, Dermatology, 2006, no. 212, Suppl 1, pp. 91-3.
50. Muller G., Kramer A. Biocompatibility index of antiseptic agents by parallel as- sessment of antimicrobial activity and cellular cytotoxicity, J. Antimicrob. Chemother., 2008, Jun., no. 61 (6), pp. 1281-7. Epub 2008, Mar 25.
51. Koburger T., Hübner N.O., Braun M., Siebert J., Kramer A. Standardized comparison of antiseptic efficacy of triclosan, PVP-iodine, octenidine dihydrochloride, poly-hexanide and chlorhexidine digluconate, J. Antimicrob. Chemother., 2010, Aug., no. 65 (8), pp. 1712-9. Epub 2010, Jun 15.
52. Van Meurs J., Gawlitta D., Heemstra K.A., Poolman R.W. et al. Selection of an Optimal Antiseptic Solution for Intraoperative Irrigation, J. Bone Joint. Surg. Am., 2014, no. 96, pp. 285-91.
53. Namba R.S., Paxton L., Fithian D.C., Stone M.L. Obesity and perioperative morbidity in total hip and total knee arthroplasty patients, J. Arthroplasty., 2005, Oct., no. 20 (7), Suppl 3., pp. 46-50.
54. Namba R.S., Inacio M.C.S., Paxton E.W. Risk Factors Associated with Deep Surgical Site Infections After Primary Total Knee Arthroplasty An Analysis of Knees, JBJS 95-A., 2013, no. 1.
55. Gandhi R., Razak F., Pathy R., Davey J.R., Syed K. et al. Antibiotic bone cement and the incidence of deep infection after total knee arthroplasty, J. Arthroplasty., 2009, Oct., no. 24 (7), pp. 1015-8.
56. Mauermann W.J., Nemergut E.C. The anesthesiologist’s role in the prevention of surgical site infections, Anesthesiology, 2006, Aug., no. 105 (2), pp. 413-21; quiz 439-40.
57. Parvizi J., Ghanem E., Joshi A., Sharkey P.F. et al. Does «excessive» anticoagulation predispose to periprosthetic infection? J. Arthroplasty., 2007, no. 22 (6 Suppl 2), pp. 24-8.
58. Galat D.D., McGovern S.C., Larson D.R., Harrington J.R. et al. Surgical treatment of early wound complications following primary total knee arthroplasty, J. Bone Joint. Surg. Am., 2009, no. 91, pp. 48-54.